» Articles » PMID: 1541382

Male Predominance of Type 1 (insulin-dependent) Diabetes Mellitus in Young Adults: Results from a 5-year Prospective Nationwide Study of the 15-34-year Age Group in Sweden

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1992 Jan 1
PMID 1541382
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of diabetes mellitus in Sweden in the 15-34 year age group was prospectively studied on a nationwide basis, beginning 1 January 1983. A total of 1,214 male and 720 female cases of newly-diagnosed (excluding gestational) diabetes were reported over a 5-year period. This corresponds to an incidence of 20.5 per 100,000/year in male subjects and 12.7 per 100,000/year in female subjects. Most cases were classified as Type 1 (insulin-dependent) diabetes, with an incidence of 15.9 in males and 8.6 in females. The incidence of Type 1 diabetes decreased gradually with age, while the incidence of Type 2 (non-insulin-dependent) diabetes increased. A male predominance was found in all age groups, with a male-to-female ratio of 1.8:1 for Type 1 diabetes and 1.3:1 for Type 2 diabetes. Maximum blood glucose concentration at diagnosis was significantly higher in males than in females in both Type 1 and Type 2 diabetic subjects. In contrast, the percent desirable weight was significantly higher in females, both in Type 1 and Type 2 diabetic subjects. The difference in diabetes incidence therefore cannot be attributed to any methodological error. The present finding of a marked male predominance after puberty in Type 1 diabetes in an ethnically quite homogeneous population supports the hypothesis that environmental risk factors and life-style are important for the development of the disease.

Citing Articles

Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.

Plengvidhya N, Suthon S, Nakdontri T, Teerawattanapong N, Ingnang S, Tangjittipokin W Diabetologia. 2025; .

PMID: 39971754 DOI: 10.1007/s00125-025-06373-y.


Incidence of type 1 diabetes in Gansu Province, Northwest China from 2018 to 2022: a multicenter, hospitalization-based study.

Zhang Y, Liu X, Yang S, Yang X, Shang M, Zhang Y Acta Diabetol. 2024; .

PMID: 39671115 DOI: 10.1007/s00592-024-02427-6.


17β-Estradiol, through activating the G protein-coupled estrogen receptor, exacerbates the complication of benign prostatic hyperplasia in type 2 diabetes mellitus patients by inducing prostate proliferation.

Yang T, Qiu Z, Shen J, He Y, Yin L, Chen L J Pharm Anal. 2024; 14(9):100962.

PMID: 39350964 PMC: 11440253. DOI: 10.1016/j.jpha.2024.03.003.


Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes.

Bass L, Bonami R Antibodies (Basel). 2024; 13(2).

PMID: 38651407 PMC: 11036271. DOI: 10.3390/antib13020027.


COVID-19 induced type 1 diabetes: A systematic review of case reports and series.

Stathi D, Katsikas Triantafyllidis K, Zafeiri M, Karalliedde J, Kechagias K J Int Med Res. 2023; 51(11):3000605231210403.

PMID: 37940619 PMC: 10637179. DOI: 10.1177/03000605231210403.


References
1.
Bingley P, Gale E . Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6. BMJ. 1989; 298(6673):558-60. PMC: 1835904. DOI: 10.1136/bmj.298.6673.558. View

2.
Teuscher A, Jarrett R . Diabetes mellitus: diagnostic criteria. Recommendations of the European Diabetes Epidemiology Study Group (EDESG) concerning the Second Report of the WHO Expert Committee on Diabetes Mellitus. Diabet Med. 1984; 1(4):305-7. DOI: 10.1111/j.1464-5491.1984.tb01979.x. View

3.
Tuvemo T, Dahlquist G, Frisk G, Blom L, Friman G, Landin-Olsson M . The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency. Diabetologia. 1989; 32(10):745-7. DOI: 10.1007/BF00274535. View

4.
Eggertsen R, Petersen K, Lundberg P, Nystrom E, Lindstedt G . Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ. 1988; 297(6663):1586-92. PMC: 1835283. DOI: 10.1136/bmj.297.6663.1586. View

5.
. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979; 28(12):1039-57. DOI: 10.2337/diab.28.12.1039. View